cabergoline

Spain

Drugs containing this active substance

  • CABERGOLINE TEVA 0.5 MG TABLETS EFG

    It is used to reduce prolactin hormone levels. It is used to suppress milk production for medical reasons, treat hormonal disorders (such as lack of ovulation or infertility), treat high prolactin levels caused by a pituitary gland tumor, by unknown causes, or due to empty sella syndrome.

    Form: tablets

    Active substance Dosage
    cabergoline 0,5 mg

    ATC: G02C G02CB G02CB03

    Manufacturer: Teva Pharma S.L.U.

  • It is used for the treatment of Parkinson's disease. It may be taken alone or together with levodopa.

    Form: tablets

    Active substance Dosage
    cabergoline 1 mg

    ATC: N04B N04BC N04BC06

    Manufacturer: Teva Pharma S.L.U.

  • It is used for the treatment of Parkinson's disease. It may be taken alone or in combination with levodopa.

    Form: tablets

    Active substance Dosage
    cabergoline 2 mg

    ATC: N04B N04BC N04BC06

    Manufacturer: Teva Pharma S.L.U.

  • It is used to prevent milk production after childbirth (when the mother decides not to breastfeed or for medical reasons) or to stop milk production following a miscarriage or the birth of a stillborn fetus. It is also used to treat disorders caused by increased prolactin hormone levels, such as the absence of menstruation, irregular cycles, lack of ovulation, or milk secretion while not breastfeeding.

    Form: tablets

    Active substance Dosage
    cabergoline 0,5 mg

    ATC: G02C G02CB G02CB03

    Manufacturer: Pfizer S.L.

  • It is used for the treatment of Parkinson's disease when other medications are ineffective or not tolerated, provided it is administered together with levodopa and a dopa-decarboxylase inhibitor.

    Form: tablets

    Active substance Dosage
    cabergoline 1 mg

    ATC: N04B N04BC N04BC06

    Manufacturer: Pfizer S.L.

  • It is used for the treatment of Parkinson's disease when other medications are ineffective or not tolerated, provided it is administered together with levodopa and a dopa-decarboxylase inhibitor.

    Form: tablets

    Active substance Dosage
    cabergoline 2 mg

    ATC: N04B N04BC N04BC06

    Manufacturer: Pfizer S.L.